Clinical Trial Update: Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating busulfan, fludarabine, and total-body irradiation as conditioning for donor stem cell transplantation in hematologic cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Precancerous Condition

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• Total Body Irradiation

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-02